110 related articles for article (PubMed ID: 3450510)
1. Effects of intraventricular administration of vasoactive intestinal peptide and neurotensin on salivary secretion and blood pressure in the rat.
Endo M; Fujita K; Kimura F
Endocrinol Jpn; 1987 Dec; 34(6):927-35. PubMed ID: 3450510
[TBL] [Abstract][Full Text] [Related]
2. Effect of intracerebroventricular injection of vasoactive intestinal polypeptide on systemic blood pressure and pancreatic and gastric secretions in the rat.
Mizuta K; Moriga M; Narusawa H; Uchino H; Aono M
Gastroenterol Jpn; 1986 Feb; 21(1):55-61. PubMed ID: 3699399
[TBL] [Abstract][Full Text] [Related]
3. Mechanism for the cardiovascular action of intracerebroventricularly administered vasoactive intestinal polypeptide in rats.
Endo M; Arita J; Fujita K; Kimura F
Exp Clin Endocrinol; 1991 Mar; 97(1):55-62. PubMed ID: 1864314
[TBL] [Abstract][Full Text] [Related]
4. Effect of intracerebroventricular injection of vasoactive intestinal polypeptide on systemic blood pressure, and pancreatic and gastric secretions in the rat.
Mizuta K; Moriga M; Narusawa H; Uchino H; Aono M
Tohoku J Exp Med; 1986 Jan; 148(1):115-6. PubMed ID: 3085283
[TBL] [Abstract][Full Text] [Related]
5. Effects of repeated infusions of substance P and vasoactive intestinal peptide on the weights of salivary glands subjected to atrophying influences in rats.
Månsson B; Nilsson BO; Ekström J
Br J Pharmacol; 1990 Dec; 101(4):853-8. PubMed ID: 1707705
[TBL] [Abstract][Full Text] [Related]
6. Effects of vasoactive intestinal polypeptide on acetylcholine stimulation of rat submandibular gland.
Endo M; Praputpittaya C; Fujita K; Kimura F
Endocrinol Jpn; 1987 Jun; 34(3):387-93. PubMed ID: 3653040
[TBL] [Abstract][Full Text] [Related]
7. TRH-induced vagal stimulation of duodenal HCO-3 mediated by VIP and muscarinic pathways.
Lenz HJ; Vale WW; Rivier JE
Am J Physiol; 1989 Nov; 257(5 Pt 1):G677-82. PubMed ID: 2531983
[TBL] [Abstract][Full Text] [Related]
8. Cardioacceleration provoked by intrathecal administration of vasoactive intestinal peptide (VIP): mediation by a non-central nervous system mechanism.
Rochford J; Henry JL
Neuropeptides; 1989; 14(4):243-52. PubMed ID: 2482950
[TBL] [Abstract][Full Text] [Related]
9. Effects of intraventricular neurotensin on blood pressure and heat balance in rats.
Shido O; Nagasaka T
Jpn J Physiol; 1985; 35(2):311-20. PubMed ID: 4046236
[TBL] [Abstract][Full Text] [Related]
10. Cardioacceleration produced by close intra-arterial injection of neurotensin into the stellate ganglion of the cat.
Bachoo M; Polosa C
Can J Physiol Pharmacol; 1988 Apr; 66(4):408-12. PubMed ID: 2458813
[TBL] [Abstract][Full Text] [Related]
11. The opposite effects of central and peripheral vasoactive intestinal polypeptide on blood pressure in rats.
Casto R; Phillips MI
Neurosci Lett; 1983 Jul; 38(2):169-73. PubMed ID: 6621937
[TBL] [Abstract][Full Text] [Related]
12. The hypotensive effect of centrally administered neurotensin in rats.
Rioux F; Quirion R; St-Pierre S; Regoli D; Jolicoeur FB; Bélanger F; Barbeau A
Eur J Pharmacol; 1981 Jan; 69(3):241-7. PubMed ID: 7215426
[TBL] [Abstract][Full Text] [Related]
13. Effects of neuropeptides on heart rate in dogs: comparison of VIP, PHI, NPY, CGRP, and NT.
Rigel DF
Am J Physiol; 1988 Aug; 255(2 Pt 2):H311-7. PubMed ID: 3261545
[TBL] [Abstract][Full Text] [Related]
14. The enhancement of carbachol-induced salivary secretion by VIP and CGRP in rat parotid gland is mimicked by forskolin.
Larsson O; Olgart L
Acta Physiol Scand; 1989 Oct; 137(2):231-6. PubMed ID: 2482655
[TBL] [Abstract][Full Text] [Related]
15. Evidence that noradrenergic activity does not mediate the inhibition of luteinizing hormone secretion caused by vasoactive intestinal peptide.
Alexander MJ; Clifton DK; Matsumoto AM; Steiner RA
Brain Res; 1988 Apr; 445(2):247-53. PubMed ID: 3130956
[TBL] [Abstract][Full Text] [Related]
16. Effects of vasoactive intestinal polypeptide on heart rate in relation to vagal cardioacceleration in conscious dogs.
Roossien A; Brunsting JR; Nijmeijer A; Zaagsma J; Zijlstra WG
Cardiovasc Res; 1997 Feb; 33(2):392-9. PubMed ID: 9074704
[TBL] [Abstract][Full Text] [Related]
17. VIP and noncholinergic vasodilatation in rabbit submandibular gland.
Fazekas A; Gazelius B; Edwall B; Theodorsson-Norheim E; Blomquist L; Lundberg JM
Peptides; 1987; 8(1):13-20. PubMed ID: 2437546
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the effects of vasoactive intestinal peptide (VIP) on blood flow through and salivation of the dog salivary gland in comparison with those of secretin, glucagon and acetylcholine.
Shimizu T; Taira N
Br J Pharmacol; 1979 Apr; 65(4):683-7. PubMed ID: 435691
[TBL] [Abstract][Full Text] [Related]
19. Central pressor action of neurotensin in conscious rats.
Sumners C; Phillips MI; Richards EM
Hypertension; 1982; 4(6):888-93. PubMed ID: 6815078
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion.
Huang SK; Pan JT
Neuroendocrinology; 1996 Sep; 64(3):208-14. PubMed ID: 8875438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
